Skin Integrity offers several services that can assist GPs in the management of their patients. These services involve aspects of skin cancer surveillance, diagnosis, surgical and non-surgical management. GPs are welcome to refer patients for an opinion; management of a specific problem or ongoing management of high risk patients. Referral forms are available to assist with this process and Dr Wassall will correspond with the referring GP. In addition, Skin Integrity also offers sessional use of its theatre facilities for GPs that wish to manage their skin cancer patients personally (see below for more details).

TBP has become an invaluable tool for assisting early melanoma detection in high risk patients. Studies have also found TBP useful for assisting detection of non-melanoma skin cancer in at risk patients over the age of 50. TBP is a surveillance tool designed to provide baseline images that the patient can use to allow them to perform comparison checks at home. It is also a very useful method of improving sensitivity during full skin examinations performed by doctors.
Photographs are performed in a dedicated studio environment by our Registered Nurse. Around 30 high resolution photos are taken to document over 90% of the cutaneous surface. Images are kept on Skin Integrity's server and a copy is provided to the patient on USB. A full skin examination is not performed and the patient is returned to their usual GP for ongoing care. An SMS message is sent to the patient approximately every 3 months to remind them to check their skin with the aid of the photographs. Any change or new lesion noted by the patient necessitates follow up by the patients GP.
For more information on Total Body Photography click here.
Consultations for specific management includes the following:
PDT is a non-surgical treatment option for field treatment of actinic keratoses as well as management of certain non-melanoma skin cancers (particularly superficial BCCs and Bowen's Disease). PDT involves incubation of the area or lesion with a photosensitiser followed by activation of the photosensitiser with a light source (specific wavelengths from an LED light source are used).
At present, Skin Integrity is using compunded 5-aminolevulinic acid (5-ALA) as the photosensitiser. There have been concerns raised about the stability of compounded 5-ALA. A more stable photosensitiser, metvix, is available in Australia but it is cost prohibitve, particularly when used as a field treatment for actinic keratoses. From early 2012, Skin Integrity will also be offering metvix as a photosensitiser. Metvix is subsidised for DVA patients and, in Dr Wassall's opinion, will be a superior photosensitiser than compounded 5-ALA particularly for treatment of nodular BCCs and treatment of supericial BCCs and Bowen's Disease in areas at high risk of recurrence such as the nose and ears.
PDT is an excellent treatment for actinic keratoses. Current research suggest that actinic keratoses are dynamic with some lesions regressing, some remaining stable and a small percentage progessing to invasive SCC. For patients with signs of extensive solar damage and actinic keratoses, particulary on the face, field treatment of the entire area is considered superior to treatment of individual lesions. A single PDT treatment has similar efficacy to treatment with efudix or aldara but with significantly less social downtime and superior cosmetic outcomes. Skin Integrity will continue to use compounded 5-ALA for this procedure due to cost considerations. However, subsidised field treatment for actinic keratoses with metvix is available for DVA patients.
PDT is considered the treatment of choice for these lesions in certain circumstances such as large lesions in difficult to heal areas such as lower limbs. Generally two treatments are required to achieve a cure rate of around 85 to 90%. Skin Integrity currently uses compounded 5-ALA for this treatment but from early 2012 will also offer metvix. Metvix treatment will be considerably more expensive. However, DVA patients qualify for subsidised metvix PDT for biopsy proven superficial BCCs and Bowen's Disease.
Metvix PDT is a suitable treatment for nodular BCCs under certain circumstances. It gives excellent cosmetic outcomes with good cure rates. It is only suitable for lesions less than 1mm in depth (due to penetration limnitations of the light source) and is not suitable for aggressive histological subtypes of BCC such as morphoeic or micronodular BCCs.
Generally two treatments are required one to two weeks apart. Compounded 5-ALA is not used at Skin Integrity for nodular BCCs.
Skin Integrity has available a dedicated operating theatre with quality surgical instruments and nursing support. GPs that wish to perform procedures within this facility can book the theatre on a sessional basis. Sessions are generally of 3.5 hours duration. Apart from offering a dedicated environment to perform these procedures, doctors also have the opportunity to potentially significantly increase their income from performing minor surgery.
The arrangements for this service are as follows:
Skin Integrity is a privately billing, premium facility which focuses on delivering high quality Skin Cancer diagnosis and treatment. Fees are set accordingly to allow us to deliver this level of service. We are paperless and have Registered Nurses to assist in dermoscopic assessment and photography, total body photography, performing punch biopsies and basic suturing, administering local anaesthetic, theatre set up and assisting, dressings and suture removal.
At present, Dr Wassall is running this clinic independently. His vision is to expand this model of care with similarly minded doctors. Initially this will occur at our current location in Terrigal but ultimately he wishes to expand and open a purpose built facility. If you have recognised post graduate experience and training in Skin Cancer medicine and dermoscopy, a commitment to excellence and are interested in joining the team, please contact Dr Wassall on 4384 6191 or email your CV to doctor@skinintegrity.com.au.
Skin Integrity provides educational newsletters designed to keep subscribers up to date with the latest happenings in the world of Cosmetic Medicine.